Skip to main content

Controlled-Medicine Stock: Authority, Balances and Discrepancies

Controlled-medicine stock verification starts with authority for the specific substance and activity, then reconciles documented movements with a physical count in the same unit. Keep usable, quarantined and otherwise restricted stock distinguishable, investigate unexplained differences and preserve the original evidence. A double-lock slogan or a generic inventory template does not establish compliance with every NDPS, drug-licensing or state requirement.

By Bractis · Updated · 9 min read

Indian clinics and appropriately authorised medical institutions reviewing custody and records for medicines subject to additional controls.

Identify the medicine and the authority before designing the register

'Controlled medicine' is an umbrella description, not one legal category with one identical register. Establish the exact substance, formulation, strength and activity: possession, procurement, dispensing, administration or transfer. The permissions and records must match those facts.

Do not assume every psychiatric medicine has the same NDPS status, or that every medicine discussed as an opioid follows one storage arrangement. Likewise, a doctor's ability to prescribe does not automatically answer every institutional possession or supply question.

For essential narcotic drugs held by a recognised medical institution, CBN's published NDPS rules identify Form 3H under Rule 52R for daily accounts. That specific context should not be silently expanded into a universal form for all clinic medicines.

Delhi Drugs Control's current RMI page illustrates recognition and reporting responsibilities at state level. Other states and arrangements need their own applicable verification. Keep the authority, validity and responsible professional identifiable in the clinic's records.

Document the applicable requirements with the authorised professional or regulator before introducing a digital stock sheet. The software may support the record, but it does not grant a licence or replace an institution-specific condition.

Source: CBN: Narcotic Drugs and Psychotropic Substances Rules, 1985

Source: Delhi Drugs Control: Procedure for recognised medical institutions

Use one stock identity and an unambiguous counting unit

Create a distinct stock identity for each formulation and strength that must be accounted for separately. A box, strip, tablet, ampoule and millilitre are not interchangeable. Record the purchasing unit and the accountable base unit with a verified conversion where relevant.

A receipt of two boxes should not add '2' to a ledger that counts individual units. Confirm the actual pack contents and any partial packs. If a product or pack changes, review the conversion before accepting the next receipt.

Count physically present items without concealing their condition. Sealed usable stock, damaged units and stock awaiting a formal disposition may all be physically present, while only some is available for use. Preserve those distinctions according to the applicable record requirements.

Define custody and authorised access: who receives stock, who may supply it, who counts it and who investigates a difference. The actual security arrangement must follow the applicable requirements and competent advice; this article does not prescribe one lock design for every clinic.

Arrange staff handovers so responsibility does not become ambiguous during leave or shift changes. A signature without a clear stock reference or unresolved-difference note provides little evidence of what the person accepted.

Record the event that changed stock

Link a receipt to the actual consignment and supplier documentation. A purchase order or paid invoice alone does not prove the goods were physically received in the expected quantity and condition.

Link an issue to the authorised activity and relevant patient or transaction record. A prescription, reservation or draft order is not automatically a completed supply. Keep the prescribed amount and the amount actually issued distinguishable where they differ.

Preserve returns, transfers, breakage and other exceptional movements through the approved process. Do not use a miscellaneous adjustment to bypass the required authority or evidence for the event. The reason and author must remain available.

Form 3H's published notes describe daily completion and separate accounts for each essential narcotic drug in the RMI context. The original working worksheet below supports reconciliation; it is not a replacement for that prescribed record or any required patient and reporting records.

Record the time of the event and the time of a later entry when they differ. Back-entering an evidenced movement should not be presented as a contemporaneous entry, and correcting a mistake should not erase the original explanation.

Source: CBN: Narcotic Drugs and Psychotropic Substances Rules, 1985

Reconcile the book balance before explaining a difference

Use a fictional stock item counted in sealed individual units. Opening stock is 50; documented receipts are 20; completed issues are 17; and an authorised, documented return removes three. The expected physical balance is 50 + 20 − 17 − 3 = 50 units.

The physical count finds 49. The discrepancy is one unit short. Of the 49 physically present, three are quarantined, leaving 46 usable under the example's stated classification. Do not subtract quarantine twice or call the book balance 46 merely to agree with available stock.

The first task is to verify the evidence and units: recount under the approved process, check pack conversion, compare the cutoff time and review movements around that time. An issue recorded after the count but physically completed before it can create a timing difference.

If the difference remains unexplained, preserve it and escalate through the authorised clinical, management and regulatory route appropriate to the substance and circumstances. A balancing entry labelled 'wastage' is not evidence of what happened.

Patient-care continuity needs separate professional handling where a discrepancy affects supply. Do not make a receptionist substitute a product, use quarantined stock or delay necessary escalation to make the ledger easier to close.

On a narrow screen, scroll the table horizontally to read all columns.

Fictional controlled-stock reconciliation in sealed individual units
ItemQuantityMeaning
Opening plus receipts50 + 2070 units accounted for before outflows
Issues plus return17 + 320 documented units removed
Expected physical stock50Book balance at the stated cutoff
Counted physical stock49One-unit unexplained shortage
Quarantined subset3 of the 49Present but not available for use
Usable stock46Does not resolve the one-unit difference

Preserve the discrepancy investigation

Keep the original count result and the exact cutoff time. If the first count used a different unit or missed an authorised storage location, explain that correction rather than replacing the result without history.

Separate a counting mistake, an entry mistake and an unexplained loss. They can produce the same numerical difference but require different responses. The investigation record should state which evidence supports the conclusion.

Review the relevant movement records and access information through authorised channels. Limit circulation of patient-linked and security-sensitive material to those who need it. Staff rumours or a convenient assumption about a person are not evidence.

When a correction is approved, show the before and after balance, the supporting event and the reviewer. Preserve any required reporting and follow-up separately. A corrected arithmetic total does not by itself close an incident.

If the process repeatedly depends on one person remembering an unrecorded movement, fix the handover and recording practice. More frequent counting may reveal the same problem sooner, but it does not remove the underlying cause.

Test the record system against real exceptions

Use fictional transactions to test a receipt in packs, an issue in individual units, an interrupted entry, a return and a count discrepancy. Confirm that a user cannot make an unexplained difference vanish merely by overwriting the opening balance.

Verify the record remains legible in the required maintained form and export. An attractive stock dashboard may omit the authority, patient linkage or movement history needed to explain the daily account.

Check who can amend records and how an amendment is attributed. Shared logins weaken the ability to distinguish the person entering a movement from the person approving a correction. Align roles with the actual authorised arrangement.

Plan retrieval across staff changes and software migration. Preserve the applicable records and evidence for the required period, including any longer hold relevant to an investigation. Do not assume a general inventory-retention default settles controlled-drug obligations.

Review the substance-specific requirements when procurement, formulation, institution status or the responsible professional changes. A previously approved workflow may no longer describe the new activity.

A box-to-unit error at receipt

In a fictional authorised setting, staff receive two packs containing ten sealed units each but enter a receipt of two units. The later count appears 18 units higher than the ledger. The team verifies the pack evidence, corrects the receipt through the approved process and retains the original entry and explanation. It also corrects the product's pack conversion before the next delivery. The finding is not treated as unexplained excess merely because the first screen showed a difference.

Controlled-stock reconciliation worksheet

Use these prompts in your clinic’s own notes. Record the result, responsible person and next action for each item.

Authority
Which substance-specific regime, institution permission and responsible professional apply to the actual activity?
Units and movements
Can each receipt and issue be reconciled in the same accountable unit with its source evidence?
Count and condition
What is physically present, what is restricted, and what difference remains against the book balance at one cutoff?
Investigation
Who reviews the discrepancy, approves corrections and determines any required reporting without erasing the initial evidence?

Questions doctors ask

Does one stock register cover every narcotic and psychotropic medicine?

Do not assume so. Identify the exact substance, activity and applicable legal regime. The Form 3H discussion here is specifically about essential narcotic drugs in recognised medical institutions.

Does double-lock storage by itself establish compliance?

No. Authority, permitted activity, custody, records and applicable conditions also matter. The required security arrangement must be established for the actual setting rather than inferred from a generic checklist.

Should quarantined units disappear from the physical count?

No. Keep their physical presence and restricted availability distinguishable according to the applicable records. In the fictional example, three quarantined units are included in the 49 physically present but excluded from the 46 usable units.

Can staff post a wastage adjustment to close an unexplained shortage?

An unexplained difference needs investigation and authorised handling. A balancing entry is not evidence of wastage. Preserve the original count, supporting records, decision and any required follow-up.

Does a digital inventory screen replace prescribed controlled-drug records?

Not automatically. Verify the applicable record format, contents, access, maintenance and retrieval requirements. A software workflow supports the authorised process; it does not grant permission or certify compliance.

Sources and scope

Updated on . This is an original stock-reconciliation guide, not a controlled-substance handling authorisation or a complete statement of current central and state law. The cited prescribed-form context is deliberately limited to the relevant RMI provisions. No independent clinical or legal review is claimed.

Try the workflow
with Bractis.

Use a fictional pack-conversion error and a one-unit discrepancy to examine the stock-history and permission features available in Bractis. Confirm the required maintained records with the authorised professional before operational use.

Request a clinic demo